Search - tctmd.com

Displaying 321 - 340 of 1546

Sort: Relevancy | Date

News Daily News

Un Estudio Explora el Uso en el ‘Mundo Real’ de Prasugrel vs. Clopidogrel en el Manejo del SCA

May 12, 2015

News Daily News

Study Explores ‘Real-World’ Use of Prasugrel vs Clopidogrel in ACS

May 12, 2015

News Industry News

InspireMD Announces Clinical Presentations on CGuard and MGuard Systems with MicroNet™ Technology at EuroPCR 2015 Conference

May 12, 2015

News Daily News

替卡格雷比氯吡格雷更快地抑制接受临时PCI的低风险ACS患者的血小板活性

Todd Neale

May 11, 2015

News Daily News

Ticagrelor Suprime Más Rápidamente la Inhibición Plaquetaria que Clopidogrel en Pacientes SCA de Riesgo Bajo durante la realización de PCI Ad Hoc

Todd Neale

May 11, 2015

News Daily News

Ticagrelor More Rapidly Suppresses Platelet Activity Than Clopidogrel for Low-Risk ACS Patients During Ad Hoc PCI

Todd Neale

May 11, 2015

News Daily News

Un Estudio de ‘Pacientes No Seleccionados’ Revela un Beneficio sobre la Supervivencia derivado de Revascularizaciones Completas en Pacientes Con y Sin Diabetes

Caitlin E. Cox

May 08, 2015

News Daily News

“所有患者”研究表明完全血运重建能改善有或无糖尿病患者的生存率

Caitlin E. Cox

May 08, 2015

News Daily News

‘All-Comers’ Study Shows Survival Benefit of Complete Revascularization in Patients With, Without Diabetes

Caitlin E. Cox

May 08, 2015

News Industry News

Device to Sand Away Severe Calcium in Coronary Arteries Shows Long-Term Positive Results in a Difficult-to-Treat Patient Population

May 07, 2015

News Industry News

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

May 07, 2015

News Daily News

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

L.A. McKeown

May 06, 2015

News Daily News

基线肌钙蛋白I升高与选择性PCI患者的易碎斑块有联系

Caitlin E. Cox

May 01, 2015

News Daily News

Unos Niveles Basales de Troponina I Más Altos se asocian a Placa Vulnerable en Pacientes sometidos a PCI

Caitlin E. Cox

May 01, 2015

News Daily News

Higher Baseline Troponin I Linked to Vulnerable Plaque in Elective PCI Patients

Caitlin E. Cox

May 01, 2015

News Daily News

分期 PCI 和 TAVR 之间的时间对短期结局有极轻微影响

Yael L. Maxwell

April 29, 2015

News Daily News

Societies Offer Guidance on Clinical Utility of Circulatory Assist Devices

L.A. McKeown

April 29, 2015

News Daily News

Length of Time Between Staged PCI, TAVR Minimally Affects Short-term Outcomes

Yael L. Maxwell

April 29, 2015

News Daily News

Leadless Pacemaker Performs Well Through 1 Year

Yael L. Maxwell

April 29, 2015

News Daily News

El Tiempo Transcurrido entre PCI por Etapas y TAVR Influye Mínimamente en los Resultados a Corto Plazo

Yael L. Maxwell

April 29, 2015

Advertisement

Un Estudio Explora el Uso en el ‘Mundo Real’ de Prasugrel vs. Clopidogrel en el Manejo del SCA

Study Explores ‘Real-World’ Use of Prasugrel vs Clopidogrel in ACS

InspireMD Announces Clinical Presentations on CGuard and MGuard Systems with MicroNet™ Technology at EuroPCR 2015 Conference

替卡格雷比氯吡格雷更快地抑制接受临时PCI的低风险ACS患者的血小板活性

Ticagrelor Suprime Más Rápidamente la Inhibición Plaquetaria que Clopidogrel en Pacientes SCA de Riesgo Bajo durante la realización de PCI Ad Hoc

Ticagrelor More Rapidly Suppresses Platelet Activity Than Clopidogrel for Low-Risk ACS Patients During Ad Hoc PCI

Un Estudio de ‘Pacientes No Seleccionados’ Revela un Beneficio sobre la Supervivencia derivado de Revascularizaciones Completas en Pacientes Con y Sin Diabetes

“所有患者”研究表明完全血运重建能改善有或无糖尿病患者的生存率

‘All-Comers’ Study Shows Survival Benefit of Complete Revascularization in Patients With, Without Diabetes

Device to Sand Away Severe Calcium in Coronary Arteries Shows Long-Term Positive Results in a Difficult-to-Treat Patient Population

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

Post-TAVR Thrombus May Be More Common Than Thought, Often Subclinical

基线肌钙蛋白I升高与选择性PCI患者的易碎斑块有联系

Unos Niveles Basales de Troponina I Más Altos se asocian a Placa Vulnerable en Pacientes sometidos a PCI

Higher Baseline Troponin I Linked to Vulnerable Plaque in Elective PCI Patients

分期 PCI 和 TAVR 之间的时间对短期结局有极轻微影响

Societies Offer Guidance on Clinical Utility of Circulatory Assist Devices

Length of Time Between Staged PCI, TAVR Minimally Affects Short-term Outcomes

Leadless Pacemaker Performs Well Through 1 Year

El Tiempo Transcurrido entre PCI por Etapas y TAVR Influye Mínimamente en los Resultados a Corto Plazo

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content